We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+17.1%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$72.5B
AUM Growth
+$8.64B
(+14%)
Cap. Flow
-$411M
Cap. Flow
% of AUM
-0.57%
Top 10 Holdings %
Top 10 Hldgs %
21.89%
Holding
3,099
New
114
Increased
2,324
Reduced
599
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$278M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$23.1M |
| 3 |
Morgan Stanley
MS
|
+$22.8M |
| 4 |
AIRC
Apartment Income REIT Corp.
AIRC
|
+$18.5M |
| 5 |
Peloton Interactive
PTON
|
+$17.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$108M |
| 2 |
Microsoft
MSFT
|
+$73.2M |
| 3 |
Amazon
AMZN
|
+$49.5M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$27.8M |
| 5 |
Meta Platforms (Facebook)
META
|
+$22.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.78% |
| 2 | Financials | 13.46% |
| 3 | Healthcare | 13.26% |
| 4 | Consumer Discretionary | 12.31% |
| 5 | Communication Services | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2976
Savara
SVRA
$1.19B
| $81K | ﹤0.01% |
70,848
+10,135
| +17% | +$12.2K |
|
2977
Exicure
XCUR
$8.57M
| $81K | ﹤0.01% |
307
+37
| +14% | +$9.26K |
|
|
SLNO
2978
DELISTED
Soleno Therapeutics
SLNO
| $79K | ﹤0.01% |
2,738
+743
| +37% | +$21.4K |
|
|
AGFS
2979
DELISTED
AgroFresh Solutions Inc
AGFS
| $78K | ﹤0.01% |
34,257
+6,242
| +22% | +$14.7K |
|
2980
Prospect Capital
PSEC
$1.17B
| $75K | ﹤0.01% |
13,794
+32
| +0.2% | +$169 |
|
|
ARAV
2981
DELISTED
Aravive, Inc. Common Stock
ARAV
| $75K | ﹤0.01% |
+13,260
| New | +$72.8K |
|
|
PTRS
2982
DELISTED
Partners Bancorp Common Stock
PTRS
| $75K | ﹤0.01% |
+11,489
| New | +$66.9K |
|
|
NYMX
2983
DELISTED
Nymox Pharmaceutical Corp
NYMX
| $75K | ﹤0.01% |
30,367
+3,833
| +14% | +$8.47K |
|
2984
Ultralife
ULBI
$106M
| $72K | ﹤0.01% |
+11,129
| New | +$70.2K |
|
|
SBBP
2985
DELISTED
Strongbridge Biopharma plc.
SBBP
| $72K | ﹤0.01% |
29,736
+4,595
| +18% | +$11.1K |
|
|
STEX
2986
Streamex Corp
STEX
$83M
| $71K | ﹤0.01% |
1,821
+180
| +11% | +$7.91K |
|
2987
Lloyds Banking Group
LYG
$91.3B
| $71K | ﹤0.01% |
36,014
-2,355
| -6% | -$3.97K |
|
2988
Target Hospitality
TH
$1.64B
| $70K | ﹤0.01% |
44,352
+6,168
| +16% | +$8.79K |
|
2989
VolitionRx Ltd
VNRX
$9.34M
| $69K | ﹤0.01% |
889
+110
| +14% | +$7.57K |
|
|
SCTL
2990
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $69K | ﹤0.01% |
24,096
+1,420
| +6% | +$3.2K |
|
2991
NLI Holdings
NL
$317M
| $68K | ﹤0.01% |
14,285
+1,747
| +14% | +$8.23K |
|
2992
Avalo Therapeutics
AVTX
$983M
| $66K | ﹤0.01% |
9
+2
| +29% | +$13.9K |
|
|
CDTX
2993
DELISTED
Cidara Therapeutics
CDTX
| $65K | ﹤0.01% |
1,617
+439
| +37% | +$21.8K |
|
2994
NextDecade
NEXT
$1.78B
| $65K | ﹤0.01% |
31,177
+4,117
| +15% | +$10.4K |
|
|
TEF
2995
DELISTED
Telefonica
TEF
| $65K | ﹤0.01% |
18,179
-1,010
| -5% | -$3.41K |
|
|
NH
2996
DELISTED
NantHealth, Inc
NH
| $65K | ﹤0.01% |
1,350
+139
| +11% | +$5.23K |
|
|
RVLP
2997
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $64K | ﹤0.01% |
15,535
+1,435
| +10% | +$8.27K |
|
2998
Galectin Therapeutics
GALT
$348M
| $63K | ﹤0.01% |
28,264
+2,830
| +11% | +$7.43K |
|
2999
Liquidia Corp
LQDA
$8.02B
| $63K | ﹤0.01% |
21,510
+2,790
| +15% | +$10.2K |
|
3000
ReposiTrak
TRAK
$159M
| $63K | ﹤0.01% |
13,162
+2,239
| +20% | +$10.8K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2020 Portfolio in Review
As of Q4 2020, RhumbLine Advisers held 3,099 positions worth $72.5B, up 14% from $63.8B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers's Q4 2020 filing shows 114 new, 2,324 increased, 599 reduced and 47 closed positions. Its largest new stake was Apartment Income REIT Corp.: 482,605 shares worth $18.5M. The largest sale was Apple, an estimated $108M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2020 buy was Apartment Income REIT Corp.: 482,605 shares worth $18.5M.
- RhumbLine Advisers added most to Tesla in Q4 2020, an estimated $278M increase.
- RhumbLine Advisers's biggest Q4 2020 reduction was Apple, cutting an estimated $108M.
- RhumbLine Advisers fully exited Immunomedics Inc in Q4 2020, selling an estimated $20.4M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $72.5B portfolio in Q4 2020.
- RhumbLine Advisers opened 114 new positions and closed 47 in Q4 2020.
- RhumbLine Advisers's portfolio value rose 14% quarter-over-quarter to $72.5B.
Based on RhumbLine Advisers's 13F filing for Q4 2020, filed 10 Feb 2021.